al with a leading Egyptian pharmaceutical company to manufacture more than 40 million doses EFTA00150545 annually in Cairo." According to the AP, the Russian Direct Investment Fund, "along with Egypt's Minapharm and its Berlin-based subsidiary, issued a joint press release saying the technology transfer will begin immediately.